Miracle Mile Advisors’s Xeris Biopharma Holdings XERS Stock Holding History

Miracle Mile Advisors’s Portfolio XERS Stock Details XERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-30,300	Closed	-$74K	–	482
2021 Q3	$74K	Hold	30,300	–	–	﹤0.01%	412
2021 Q2	$123K	Sell	30,300 -60,000	-66%	-$229K	0.01%	370
2021 Q1	$407K	Sell	90,300 -29,000	-24%	-$156K	0.02%	271
2020 Q4	$587K	Buy	119,300 +29,000	+32%	+$145K	0.04%	248
2020 Q3	$535K	Buy	+90,300	New	+$361K	0.04%	242

Other funds holding XERS

Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Miracle Mile Advisors's XERS Position: Q4 2021 in Review

Miracle Mile Advisors sold out of Xeris Biopharma Holdings (XERS) in Q4 2021, closing a stake of 30,300 shares — an estimated $74K sold.

Miracle Mile Advisors first reported a position in XERS in Q3 2020 and held it in 5 quarters. The position peaked at $587K in Q4 2020. 92 funds tracked by Wall St. Rank hold XERS as of Q4 2021.

Miracle Mile Advisors reported no remaining Xeris Biopharma Holdings position as of Q4 2021 after selling out during the quarter.
Miracle Mile Advisors sold 30,300 Xeris Biopharma Holdings shares in Q4 2021, an estimated $74K.
Miracle Mile Advisors first reported a position in Xeris Biopharma Holdings in Q3 2020 and held it in 5 quarters.
Miracle Mile Advisors's Xeris Biopharma Holdings position peaked at $587K in Q4 2020.
92 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q4 2021.

Based on Miracle Mile Advisors's 13F filing for Q4 2021, filed 18 Jan 2022.